What is YD Bio Ltd's share price today?
YD Bio Ltd (YDES) share price today is $2.91 as of September 21, 2026 at 10:30 PM IST. The stock touched a day high of $3.49 and a day low of $2.88.What exchange does YD Bio Ltd stock trade on, and under what ticker symbol?
YD Bio Ltd stock trades on NASDAQ under the ticker symbol YDES.What is YD Bio Ltd's market capitalization?
YD Bio Ltd's market capitalization is $225.95M as of September 21, 2026 at 10:30 PM IST.What is YD Bio Ltd's price-to-earnings (P/E) ratio?
YD Bio Ltd's price-to-earnings (P/E) ratio is 0 as of September 21, 2026.What is YD Bio Ltd's price-to-book (P/B) ratio?
YD Bio Ltd's price-to-book (P/B) ratio is 51.14 as of September 21, 2026.Can Indian investors buy YD Bio Ltd shares?
Yes, You can buy YD Bio Ltd shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in YD Bio Ltd shares from India?
Indian investors can buy YD Bio Ltd shares in three steps: 1. Search YD Bio Ltd on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from YD Bio Ltd shares for Indian investors?
Since YD Bio Ltd trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in YD Bio Ltd shares via Tickertape?
Indian investors can start investing in YD Bio Ltd (YDES) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.4305 shares at the current price of $2.91.
$
₹
$2.918.62% (-0.27)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
0
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
51.14
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$0
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
24.67%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Company Profile
Peers
Peers
ABBV
P/E Ratio
74.56
74.56
1Y Return
19.79%
19.79%
Buy Reco %
57.14
57.14
AMGN
P/E Ratio
23.98
23.98
1Y Return
38.66%
38.66%
Buy Reco %
46.87
46.87
P/E Ratio
—
—
1Y Return
32.8%
32.8%
Buy Reco %
63.33
63.33
P/E Ratio
29.58
29.58
1Y Return
31.31%
31.31%
Buy Reco %
52.94
52.94
P/E Ratio
19.41
19.41
1Y Return
31.25%
31.25%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
HealthcareBiotechnology
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| YD Bio Ltd | 0 | 51.14 | - |
| AbbVie Inc | 74.56 | 50.45 | 0.54 |
| Amgen Inc | 23.98 | 17.83 | 2.32 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q1 2025
Q2 2025
Q4 2025
Q2 2026
Revenue
Net Income
| Financial Year | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q4 2025 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - |
| Net Income | 0.69 | -22.01 | 17.10 | 2.18 | 0.41 | -3.36 | -2.21 | - | - |
| Net Profit Margin | - | - | - | - | - | - | - | - | - |
